Results 91 to 100 of about 464,460 (389)

Haematological Performances of Jaundice Catfish (Clarias gariepinus, Burch) [PDF]

, 2012
The research was aimed to study hematological performances of jaundice and healthy catfish (Clarias gariepinus, Burch.). Fifty fish (i.e. twenty five of jaundice and twenty five of healthy catfish) were collected and analyzed for their hematological ...
Hastuti, Sri, Subandiyono, Subandiyono
core  

Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This paper describes the development of a microscale model that quantifies the breakdown of fibrin by endothelial cells. The small size scale of this engineered system enables fibrin breakdown to be observed without the addition of external activators. This system could help in identifying compounds which both promote and hinder thrombosis.
Jonathan J. Chang, Kelsey Brew, Jamie A.G. Hamilton, Varun Kumar, José A. Diaz, Shuichi Takayama   +5 more
wiley   +1 more source

Magnitudes of Risk Factors of Venous Thromboembolism and Quality of Anticoagulant Therapy in Ethiopia: A Systematic Review

Vascular Health and Risk Management, 2022
Bekalu Kebede, Tirsit Ketsela Clinical Pharmacy Unit, Pharmacy Department, Health Science College, Debre Markos University, Debre Markos, EthiopiaCorrespondence: Bekalu Kebede, Department of Pharmacy, College of Health Sciences, Debre Markos University ...
Kebede B, Ketsela T
doaj  

Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report

International Journal of Medical Toxicology and Forensic Medicine, 2020
Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects.
Abbas‎ Ghaysouri, Mahtab Bonyadi, Elham Shafiei   +2 more
doaj   +1 more source

Life‐threatening extrapleural hematoma in an anticoagulated patient 2 weeks after lobectomy

Thoracic Cancer, 2021
We report a case of an anticoagulated patient with sudden onset pleural hematoma after straining at defecation to cardiac arrest on 2 weeks after lobectomy for lung cancer.
Masanori Shimomura, Masashi Iwasaki, Reona Shimegi, Masayoshi Inoue   +3 more
doaj   +1 more source

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

JAMA cardiology, 2018
Importance Black and Hispanic patients are less likely than white patients to use oral anticoagulants for atrial fibrillation. Little is known about racial/ethnic differences in use of direct-acting oral anticoagulants (DOACs) for atrial fibrillation ...
U. Essien, D. Holmes, L. Jackson, G. Fonarow, K. Mahaffey, J. Reiffel, B. Steinberg, L. Allen, P. Chan, J. Freeman, Rosalia G. Blanco, K. Pieper, J. Piccini, E. Peterson, D. Singer   +14 more
semanticscholar   +1 more source

Delivery of Islatravir via High Drug‐Load, Long‐acting Microarray Patches for the Prevention or Treatment of Human Immunodeficiency Virus

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
Islatravir‐loaded dissolving microarray patches (MAPs) provide a minimally invasive, long‐acting solution for HIV‐1 prevention and treatment. In rats, sustained islatravir delivery lasts up to three months, while in minipigs, efficacious plasma levels are detected for six days.
Qonita Kurnia Anjani, Ashley R. Johnson, Akmal H. Sabri, Ryan Lutz, Steven Tignor, Jeanine Ballard, Nathan Rudd, Li Zhao, Lalitkumar K. Vora, Stephanie E. Barrett, Angela Wagner, Ryan F. Donnelly   +11 more
wiley   +1 more source

Atrial Fibrillation Management in Acute Stroke Patients in Türkiye: Real-life Data from the NöroTek Study

Türk Nöroloji Dergisi, 2023
Objective: Atrial fibrillation (AF) is the most common directly preventable cause of ischemic stroke. There is no dependable neurology-based data on the spectrum of stroke caused by AF in our country.
Mehmet Akif Topçuoğlu, Ethem Murat Arsava, Atilla Özcan Özdemir, Özlem Aykaç, Mustafa Çetiner, Elif Sarıönder Gencer, Aygül Güneş, Yakup Krespi, Erdem Yaka, Levent Öcek, Zeynep Tanrıverdi, Ülgen Yalaz Tekan, Ayça Özkul, Esra Özkan, Hadiye Şirin, Ayşe Güler, Oğuzhan Kurşun, Refik Kunt, Utku Cenikli, Bilgehan Acar, Yüksel Kablan, Ayşe Yılmaz, Canan Togay Işıkay, Eda Aslanbaba, Mine Sorgun, Hesna Bektaş, Murat Çabalar, Vildan Yayla, Hacı Ali Erdoğan, Mustafa Gökçe, Songül Bavli, Nedim Ongun, Ahmet Onur Keskin, Özlem Akdoğan, Ufuk Emre, Özlem Kayım Yıldız, Aslı Bolayır, Çetin Kürşad Akpınar, Hasan Hüseyin Karadeli, Tuğba Özel, Ali Ünal, Babür Dora, Zülfikar Arlıer, Alper Eren, Aysel Milanoğlu, Bijen Nazliel, Hale Batur Çağlayan, Bülent Güven, Mücahid Erdoğan, Zeynep Özdemir Acar, Mustafa Bakar, Semih Giray, Songül Şenadım, Talip Asil, Turgay Demir, Yaprak Özüm Ünsal, Neslihan Eşkut, Yıldız Aslan, Demet Funda Baş, Ufuk Şener, Bahar Değirmenci, Ufuk Aluçlu, Birgül Baştan, Zeynep Acar, Buket Niflioğlu, Duran Yazıcı, Emrah Aytaç, Fatma Birsen İnce, Halil Ay, Halil Önder, Hasan Hüseyin Kozak, İrem İlgezdi, Adnan Burak Bilgiç, Şenol Akyol, İ. Levent Güngör, Murat Mert Atmaca, Mustafa Şen, Recep Yevgi, Sinem Yazıcı Akkaş, Tahir Yoldaş, H. Tuğrul Atasoy, Bilge Piri Çınar, Arda Yılmaz, Hamit Genç, Ayşın Kısabay, Faik İlik, Hayri Demirbaş, İpek Midi, Pınar Bekdik Şirinocak, Taşkın Duman, Tülin Demir, Ufuk Can, Vedat Ali Yürekli, Zehra Bozdoğan, Zekeriya Alioğlu, Dilaver Kaya, Nazire Afşar, Erdem Gürkaş, Eren Toplutaş, Eylem Değirmenci, Gülseren Büyükşerbetçi, İsa Aydın, M. Tuncay Epçeliden, Nilda Turgut, Nilüfer Kale, Eda Çoban, Nilüfer Yeşilot, Esme Ekizoğlu, Özgü Kizek, Özlem Bilgili, Recep Baydemir, Merve Akçakoyunlu, Zahide Yılmaz, Şerefnur Öztürk   +113 more
doaj   +1 more source

Prevention of venous thromboembolism after hip and knee replacement among older adults [PDF]

, 2017
BACKGROUND: Venous thromboembolism (VTE) after total hip and knee replacement is a major patient safety threat, and pharmacologic prophylaxis is generally recommended. However, clinicians disagree on the optimal prophylaxis agent.
Ko, Darae
core  

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source